Pfizer reported lower 3rd quarter profits on Tuesday, October 27, as COVID-19 dented demand for some medicines from patients whose regular healthcare patterns were disrupted.
The company saw an 11% drop in its hospital business in emerging markets, primarily due to fewer elective surgeries in China and shorter in-patient hospital stays in the country.
이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오: